Compounds > arginine vasopressin
Page last updated: 2024-08-18

arginine vasopressin and piperidines

arginine vasopressin has been researched along with piperidines in 86 studies

Research

Studies (86)

TimeframeStudies, this research(%)All Research%
pre-19904 (4.65)18.7374
1990's54 (62.79)18.2507
2000's21 (24.42)29.6817
2010's7 (8.14)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hirata, Y; Kohmoto, O; Matsui, H; Serizawa, T1
Harada, S; Hirooka, Y; Imaizumi, T; Masaki, H; Momohara, M; Takeshita, A2
Endoh, M; Norota, I; Takanashi, M1
Chiba, S; Tsukada, M1
Chiba, S; Furukawa, Y; Inoue, Y; Ren, LM; Sawaki, S; Takayama, S1
Ishikawa, S; Okada, K; Saito, T1
Chihara, T; Kondo, K; Mori, T; Nakamura, S; Ogawa, H; Onogawa, T; Tominaga, M; Yabuuchi, Y; Yamamura, Y1
Emori, T; Hirata, Y; Marumo, F; Ohta, K; Shichiri, M1
Koch, P; Peters, T; Wilffert, B; Wilhelm, D1
Chihara, T; Mori, T; Nakamura, S; Onogawa, T; Tominaga, M; Yabuuchi, Y; Yamamura, Y; Yamashita, T1
Nakanishi, T; Nanbu, A; Nishimura, M; Sakamoto, M; Takahashi, H; Yoshimura, M3
Asano, N; Harada, K; Hashimoto, M; Kageyama, J; Mimura, Y; Ogura, T; Oishi, T; Ota, Z; Yamauchi, T1
Arakawa, K; Ichihara, A; Matsumoto, A; Murakami, M; Naitoh, M; Nakamoto, H; Oka, K; Saruta, T; Suzuki, H; Yamamura, Y1
Burrell, LM; Buxton, BF; Johnston, CI; Liu, JJ; Phillips, PA; Rolls, KA1
Delisee, C; Dol, F; Garcia, C; Herbert, JM; Le Fur, G; Maffrand, JP; Marty, E; Raufaste, D; Schaeffer, P; Serradeil-Le Gal, C1
Fukami, T; Ihara, M; Ishikawa, K; Ozaki, S; Saeki, T; Yano, M1
Donald, RA; Ellis, MJ; Evans, MJ; Mulligan, RS1
Abe, Y; Aki, Y; Fujisawa, Y; Hayashida, Y; Kimura, S; Miyatake, A; Tamaki, T1
Burrell, LM; Buxton, BB; Johnston, CI; Liu, JJ; Phillips, PA1
Gopalakrishnan, V; Herman, RJ; Sandirasegarane, L1
Ban, Y; Honda, K; Ishiharada, N; Kamiya, H; Saito, R; Takano, Y1
Bourrié, B; Carayon, P; Casellas, P; Garcia, C; Le Fur, G; Maffrand, JP; Raufaste, D; Serradeil-Le Gal, C1
Ishikawa, S; Okada, K; Saito, T; Sasaki, R1
Burrell, LM; Johnston, CI; Phillips, PA; Risvanis, J; Rolls, KA; Stephenson, JM1
Burrell, LM; Hutchins, AM; Johnston, CI; Phillips, PA; Risvanis, J; Stephenson, J2
Ichihara, A; Matsumoto, A; Murakami, M; Naitoh, M; Nakamoto, H; Saruta, T; Suzuki, H; Yamamura, Y1
Chihara, T; Mori, T; Nakamura, S; Onogawa, T; Tominaga, M; Yabuuchi, Y; Yamada, Y; Yamamura, Y; Yamashita, T1
Kribben, A; Li, X; Nemenoff, RA; Schrier, RW; Tsai, P; Wieder, ED1
Jamil, KM; Kurokawa, K; Nakao, A; Okuda, T; Watanabe, T1
Christophe, B; Garcia, C; Guiraudou, P; Lacour, C; Le Fur, G; Maffrand, JP; Nisato, D; Serradeil-Le Gal, C; Villanova, G; Wagnon, J1
Brooks, DP; DePalma, PD; Dondio, G; Edwards, RM; Gellai, M; Giardina, G; Jugus, M; Misiano, P; Petrone, G; Sbacchi, M1
Miura, Y; Nakano, H; Nakayama, M; Suzuki, S; Tuchida, H; Yamada, K; Yoshida, S1
Miura, Y; Nakano, H; Nakayama, M; Suzuki, S; Tsuchida, H; Yamada, K; Yoshida, S1
Gopalakrishnan, V; Sandirasegarane, L; Xu, Y1
Hirai, S; Kosaka, K; Mizuno, K; Nishioka, N; Ohno, S; Osada, S; Suzuki, A1
Bax, WA; Bos, E; Nisato, D; Saxena, PR; Stam, WB; Van der Graaf, PH1
Abe, K; Hashimoto, J; Imai, Y; Minami, N; Munakata, M1
Chiba, S; Furukawa, Y; Hoyano, Y; Imamura, H; Kasama, M; Nakano, H1
Hanaoka, K; Imai, M; Kurokawa, K; Naruse, M; Yamamura, Y; Yoshitomi, K1
Brooks, DP; Rossi, NF1
Iizuka, T; Nishikawa, T; Omura, M; Saito, I; Yoshida, S1
Calò, G; Regoli, D; Rizzi, A; Traina, L1
Goto, A; Hayakawa, H; Hirata, Y; Hirobe, M; Kakoki, M; Kikuchi, K; Kimura, K; Nagano, T; Nagata, D; Omata, M; Suzuki, E; Tojo, A1
Borycz, J; Bugajski, J; Gadek-Michalska, A; Głód, R; Ołowska, A1
Aldred, KL; Burrell, LM; Johnston, CI; Naitoh, M; Phillips, PA; Risvanis, J; Rockell, MD1
Ishii, N; Kusayama, T; Tahara, A; Tanaka, A; Tomura, Y; Tsukada, J; Uchida, W; Wada, K; Yatsu, T1
Charles, CJ; Donald, RA; Ikram, H; Prickett, T; Richards, AM1
Saxena, PR; Stam, WB; Van der Graaf, PH1
Daidoh, H; Hanafusa, J; Ishizuka, T; Morita, H; Mune, T; Murase, H; Sato, M; Shibata, T; Suwa, T; Yasuda, K1
Iijima, T; Ishikawa, K; Kurata, S1
Fukuzawa, J; Haneda, T; Kikuchi, K1
Fujisawa, S; Iijima, T1
Diéguez, G; Fernández, N; García-Villalón, AL; Gómez, B; Martínez, MA; Monge, L; Sánchez, MA1
Coles, P; Conarty, DM; Plesnicher, CL; Shoham, M; Thibonnier, M1
Ishiguro, S; Iwasaki, T; Miyamoto, A; Mori, T; Nishio, A1
Franco, W; Leite, RS1
Ishii, N; Kusayama, T; Tahara, A; Tanaka, A; Taniguchi, N; Tomura, Y; Tsukada, J; Uchida, W; Yatsu, T1
Ikebe, M; Kohda, Y; Machida, K; Nonoguchi, H; Star, RA; Tashima, Y; Tomita, K1
Ishii, N; Kusayama, T; Tahara, A; Tanaka, A; Taniguchi, N; Tomura, Y; Tsukada, J; Uchida, W; Wada, K; Yatsu, T1
Arima, H; Hirabayashi, M; Miura, Y; Murase, T; Nagasaki, H; Oiso, Y; Sugimura, Y; Tachikawa, K; Yokoi, H1
DAVIS, WM; RIEGER, JA1
BARRE, N; CAHN, J; HEROLD, M1
Hirate, K; Irifune, M; Nishikawa, T; Ohnishi, Y; Sato, T; Tanaka, K; Teramoto, T1
Keshavan, V; Shanthi, M; Tyagi, MG; Vikram, GS1
Aukland, K; Roald, AB; Tenstad, O1
Niederhoffer, N; Pfitzer, T; Szabo, B1
Ishii, N; Kusayama, T; Shibasaki, M; Suzuki, T; Tahara, A; Taniguchi, N; Tomura, Y; Tsukada, J; Uchida, W; Wada, K; Yatsu, T1
Ishikawa, SE; Sasaki, M1
Aoyagi, T; Hiroyama, M; Oikawa, R; Sanbe, A; Takeo, S; Tanoue, A; Wang, S1
Alves, FH; Corrêa, FM; Crestani, CC; Resstel, LB1
Shibasaki, M; Suzuki, T; Tahara, A; Tomura, Y; Tsukada, J; Yatsu, T1
Cowley, AW; O'Connor, PM1
Shimizu, T; Yokotani, K1
Shibasaki, M; Tahara, A; Tomura, Y; Tsukada, J; Yatsu, T2
Ishida, K; Kamata, K; Kobayashi, T; Matsumoto, T; Nakayama, N1
Antunes-Rodrigues, J; Elias, LL; Ruginsk, SG; Uchoa, ET1
Attkins, N; Bateman, L; Bictash, M; Doyle, R; Ivarsson, M; Neal-Morgan, S; Pullen, N; Ramsey, S; Russell, R; Turner, J; Weibley, L1
Armstrong, WE; Wang, L1
Acaz-Fonseca, E; Bellini, MJ; Garcia-Segura, LM; Grassi, D; Panzica, G1
Barrett, CE; Inoue, K; Kittelberger, KA; Landgraf, R; Modi, ME; Smith, DG; Young, LJ1
Bülbül, M; Gemici, B; İzgüt-Uysal, VN; Sinen, O1

Reviews

1 review(s) available for arginine vasopressin and piperidines

ArticleYear
[Renal action of vasopressin].
    Nihon rinsho. Japanese journal of clinical medicine, 2006, Volume: 64 Suppl 2

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Aquaporin 2; Arginine Vasopressin; Benzazepines; Diabetes Insipidus; Diabetes Insipidus, Nephrogenic; Drug Design; Humans; Hyponatremia; Inappropriate ADH Syndrome; Mutation; Piperidines; Quinolones; Receptors, Vasopressin

2006

Trials

1 trial(s) available for arginine vasopressin and piperidines

ArticleYear
Short-term clinical trial of 1-(1-[4-(3-acetylaminopropoxy)-benzoyl]-4-piperidyl)-3, 4-dihydro-2(1H)-quinolinone in patients with diabetic nephropathy. Possible effectiveness of the specific vasopressin V1 receptor antagonist for reducing albuminuria in p
    Arzneimittel-Forschung, 1996, Volume: 46, Issue:9

    Topics: Albuminuria; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Blood Glucose; Blood Pressure; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Heart Rate; Humans; Male; Middle Aged; Piperidines; Quinolones; Saline Solution, Hypertonic

1996

Other Studies

84 other study(ies) available for arginine vasopressin and piperidines

ArticleYear
Effects of a nonpeptide vasopressin antagonist (OPC-21268) on cytosolic Ca2+ concentration in vascular and cardiac myocytes.
    Hypertension (Dallas, Tex. : 1979), 1992, Volume: 19, Issue:6 Pt 2

    Topics: Animals; Arginine Vasopressin; Calcium; Cytosol; Muscle, Smooth, Vascular; Myocardium; Osmolar Concentration; Piperidines; Quinolones; Vasopressins

1992
Effects of OPC-21268, an orally effective vasopressin V1 receptor antagonist in humans.
    Hypertension (Dallas, Tex. : 1979), 1992, Volume: 20, Issue:1

    Topics: Administration, Oral; Adult; Angiotensin Receptor Antagonists; Arginine Vasopressin; Dose-Response Relationship, Drug; Forearm; Humans; Injections, Intra-Arterial; Male; Phenylephrine; Piperidines; Quinolones; Receptors, Vasopressin; Regional Blood Flow; Vascular Resistance

1992
Effects of vasopressin on phosphoinositide hydrolysis and myocardial contractility.
    European journal of pharmacology, 1992, Aug-06, Volume: 218, Issue:2-3

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Heart Ventricles; Hydrolysis; In Vitro Techniques; Male; Myocardial Contraction; Phosphatidylinositols; Piperidines; Quinolones; Rabbits; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta

1992
Potent antagonistic action of OPC-31260, a vasopressin V2 receptor antagonist, on [Arg8]vasopressin-induced vasoconstriction in isolated simian femoral arteries.
    European journal of pharmacology, 1992, Oct-20, Volume: 221, Issue:2-3

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Female; Femoral Artery; In Vitro Techniques; Macaca; Male; Norepinephrine; Piperidines; Quinolones; Vasoconstriction

1992
Blocking effects of V1 (OPC-21268) and V2 (OPC-31260) antagonists on the negative inotropic response to vasopressin in isolated dog heart preparations.
    The Journal of pharmacology and experimental therapeutics, 1992, Volume: 263, Issue:2

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Deamino Arginine Vasopressin; Dogs; Heart; Heart Atria; Perfusion; Piperidines; Quinolones; Receptors, Vasopressin

1992
Effect of a new V1 antagonist (OPC-21268) on vascular action of vasopressin in cultured rat vascular smooth muscle cells.
    Biochemical and biophysical research communications, 1991, Jul-31, Volume: 178, Issue:2

    Topics: Angiotensin II; Animals; Aorta, Thoracic; Arginine Vasopressin; Calcium; Cells, Cultured; Kinetics; Male; Muscle, Smooth, Vascular; Piperidines; Quinolones; Rats; Rats, Inbred Strains; Receptors, Angiotensin; Receptors, Vasopressin

1991
OPC-21268, an orally effective, nonpeptide vasopressin V1 receptor antagonist.
    Science (New York, N.Y.), 1991, Apr-26, Volume: 252, Issue:5005

    Topics: Administration, Oral; Angiotensin II; Animals; Arginine Vasopressin; Binding, Competitive; Blood Pressure; Cell Membrane; Kidney; Kinetics; Liver; Norepinephrine; Piperidines; Quinolones; Rats; Receptors, Angiotensin; Receptors, Vasopressin; Time Factors

1991
Vasoconstrictor-induced heterologous down-regulation of vascular atrial natriuretic peptide receptor.
    European journal of pharmacology, 1989, May-30, Volume: 164, Issue:3

    Topics: Angiotensin II; Animals; Arginine Vasopressin; Cyclic GMP; Humans; In Vitro Techniques; Iodine Radioisotopes; Muscle, Smooth, Vascular; Piperidines; Rats; Receptors, Atrial Natriuretic Factor; Receptors, Cell Surface; Tetradecanoylphorbol Acetate; Vasoconstrictor Agents

1989
R 56865 differentiates between contractile agents with respect to the nifedipine-sensitive component in the isolated rat aorta.
    Pharmacology, 1989, Volume: 39, Issue:1

    Topics: Angiotensin II; Animals; Aorta, Thoracic; Arginine Vasopressin; Benzothiazoles; Calcium; Calcium Channels; Cytosol; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nifedipine; Piperidines; Rats; Rats, Inbred Strains; Serotonin; Thiazoles

1989
OPC-21268 antagonizes arginine vasopressin-induced vasoconstrictor response in the spinally-anesthetized dog.
    Japanese journal of pharmacology, 1995, Volume: 68, Issue:3

    Topics: Animals; Arginine Vasopressin; Blood Pressure; Dogs; Dose-Response Relationship, Drug; Injections, Intravenous; Piperidines; Quinolones; Vasoconstriction

1995
Cerebral ATP-sensitive potassium channels during acute reduction of carotid blood flow.
    Hypertension (Dallas, Tex. : 1979), 1995, Volume: 25, Issue:5

    Topics: Adenosine Triphosphate; Animals; Arginine Vasopressin; Blood Pressure; Brain; Carotid Arteries; Glyburide; Male; Piperidines; Pituitary Gland; Potassium Channels; Quinolones; Rats; Rats, Wistar; Regional Blood Flow

1995
Enhanced pressor response in spontaneously hypertensive rats induced by stimulation of vasopressin-V1 receptors.
    Acta medica Okayama, 1995, Volume: 49, Issue:1

    Topics: Animals; Arginine Vasopressin; Benzazepines; Blood Pressure; Heart Rate; Hypertension; Male; Piperidines; Quinolones; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Vasopressin; Stimulation, Chemical

1995
Effects of oral AVP receptor antagonists OPC-21268 and OPC-31260 on congestive heart failure in conscious dogs.
    The American journal of physiology, 1994, Volume: 267, Issue:6 Pt 2

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Body Weight; Capillary Resistance; Cardiac Output; Cardiac Pacing, Artificial; Diuresis; Dogs; Heart Failure; Hemodynamics; Kidney; Male; Natriuresis; Osmolar Concentration; Piperidines; Potassium; Quinolones; Renin; Sodium

1994
Vascular responses to vasopressin antagonists in man and rat.
    Clinical science (London, England : 1979), 1994, Volume: 87, Issue:4

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Culture Techniques; Dose-Response Relationship, Drug; Female; Humans; Mammary Arteries; Mesenteric Artery, Superior; Piperidines; Quinolones; Rats; Rats, Sprague-Dawley; Species Specificity; Vasoconstriction

1994
Effect of SR-49059, a vasopressin V1a antagonist, on human vascular smooth muscle cells.
    The American journal of physiology, 1995, Volume: 268, Issue:1 Pt 2

    Topics: Aorta; Arginine Vasopressin; Calcium; Cell Division; Cell Membrane; Cells, Cultured; Deamino Arginine Vasopressin; Dose-Response Relationship, Drug; Humans; Indoles; Iodine Radioisotopes; Kinetics; Muscle, Smooth, Vascular; Oxytocin; Piperidines; Pyrrolidines; Quinolones; Radioligand Assay; Receptors, Vasopressin; Vasopressins

1995
Endothelin ETB receptors couple to two distinct signaling pathways in porcine kidney epithelial LLC-PK1 cells.
    The Journal of pharmacology and experimental therapeutics, 1994, Volume: 270, Issue:3

    Topics: Amino Acid Sequence; Animals; Arginine Vasopressin; Colforsin; Cyclic AMP; Cyclic GMP; Endothelin Receptor Antagonists; Endothelins; Epithelium; Glycopeptides; Kidney Tubules; LLC-PK1 Cells; Molecular Sequence Data; Oligopeptides; Peptides, Cyclic; Piperidines; Protein Binding; Receptor, Endothelin B; Receptors, Endothelin; Signal Transduction; Swine

1994
The effects of corticotrophin-releasing hormone, arginine vasopressin and their antagonists on ACTH release from perifused horse anterior pituitary cells.
    The Journal of endocrinology, 1994, Volume: 143, Issue:1

    Topics: Adrenocorticotropic Hormone; Animals; Arginine Vasopressin; Biological Assay; Cells, Cultured; Corticotropin-Releasing Hormone; Dose-Response Relationship, Drug; Drug Synergism; Female; Horses; Male; Piperidines; Pituitary Gland, Anterior; Quinolones

1994
Role of vasopressin on cardiovascular changes during hemorrhage in conscious rats.
    The American journal of physiology, 1994, Volume: 267, Issue:5 Pt 2

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Blood Pressure; Heart Rate; Hemorrhage; In Vitro Techniques; Kidney; Male; Piperidines; Quinolones; Rats; Rats, Sprague-Dawley; Renal Artery; Sympathetic Nervous System; Time Factors

1994
Human internal mammary artery responses to non-peptide vasopressin antagonists.
    Clinical and experimental pharmacology & physiology, 1994, Volume: 21, Issue:2

    Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Arteries; Benzazepines; Breast; Female; Humans; In Vitro Techniques; Muscle Contraction; Muscle, Smooth, Vascular; Norepinephrine; Piperidines; Quinolones; Receptors, Vasopressin; Regional Blood Flow

1994
High glucose attenuates peptide agonist-evoked increases in cytosolic free [Ca2+] in rat aortic smooth muscle cells.
    Diabetes, 1994, Volume: 43, Issue:8

    Topics: Alkaloids; Angiotensin II; Animals; Aorta; Arginine Vasopressin; Calcium; Cells, Cultured; Culture Media; Cytosol; Endothelins; Glucose; Male; Mannose; Muscle, Smooth, Vascular; Piperidines; Protein Kinase C; Rats; Rats, Sprague-Dawley; Staurosporine; Tetradecanoylphorbol Acetate

1994
Vasopressin V1 receptor in rat hippocampus is regulated by adrenocortical functions.
    Brain research, 1994, May-16, Volume: 646, Issue:1

    Topics: Adrenal Cortex; Adrenalectomy; Aldosterone; Animals; Arginine Vasopressin; Corticosterone; Dexamethasone; Hippocampus; Male; Piperidines; Quinolones; Rats; Rats, Wistar; Receptors, Vasopressin

1994
Effect of a new, potent, non-peptide V1a vasopressin antagonist, SR 49059, on the binding and the mitogenic activity of vasopressin on Swiss 3T3 cells.
    Biochemical pharmacology, 1994, Feb-11, Volume: 47, Issue:4

    Topics: 3T3 Cells; Animals; Arginine Vasopressin; Binding Sites; Cell Division; DNA; Flow Cytometry; Indoles; Mice; Mitogens; Piperidines; Pyrrolidines; Quinolones; Receptors, Vasopressin

1994
Distinct inhibition by non-peptide and peptide arginine vasopressin antagonists of vasopressin-induced activation of mitogen-activated protein kinase in cultured rat vascular smooth muscle cells.
    Biochemical and biophysical research communications, 1994, Apr-29, Volume: 200, Issue:2

    Topics: Angiotensin II; Animals; Arginine Vasopressin; Calcium-Calmodulin-Dependent Protein Kinases; Cells, Cultured; Enzyme Activation; Ionomycin; Muscle, Smooth, Vascular; Piperidines; Quinolones; Rats; Tetradecanoylphorbol Acetate

1994
Blood pressure-lowering effect of an orally active vasopressin V1 receptor antagonist in mineralocorticoid hypertension in the rat.
    Hypertension (Dallas, Tex. : 1979), 1994, Volume: 23, Issue:6 Pt 1

    Topics: Administration, Oral; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Binding Sites; Blood Pressure; Desoxycorticosterone; Female; Hypertension; Kinetics; Mesenteric Arteries; Piperidines; Quinolones; Rats; Rats, Sprague-Dawley; Receptors, Vasopressin; Sodium Chloride; Systole; Vascular Resistance

1994
Characterization of a novel non-peptide vasopressin V1 receptor antagonist (OPC-21268) in the rat.
    The Journal of endocrinology, 1993, Volume: 138, Issue:2

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Dose-Response Relationship, Drug; Female; In Vitro Techniques; Kidney Medulla; Liver; Piperidines; Protein Binding; Quinolones; Radioligand Assay; Rats; Rats, Sprague-Dawley; Time Factors

1993
Arginine vasopressin produces renal vasodilation via V2 receptors in conscious dogs.
    The American journal of physiology, 1993, Volume: 265, Issue:4 Pt 2

    Topics: Animals; Arginine Vasopressin; Benzazepines; Deamino Arginine Vasopressin; Diuresis; Dogs; Drug Combinations; Hemodynamics; Male; Natriuresis; Osmolar Concentration; Piperidines; Quinolones; Receptors, Vasopressin; Renal Circulation; Vasodilation

1993
OPC-21268, a vasopressin V1 antagonist, produces hypotension in spontaneously hypertensive rats.
    Hypertension (Dallas, Tex. : 1979), 1994, Volume: 23, Issue:2

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Blood Pressure; Hypertension; Male; Piperidines; Quinolones; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley

1994
Inhibition of vasopressin action in vascular smooth muscle by the V1 antagonist OPC-21268.
    Hypertension (Dallas, Tex. : 1979), 1994, Volume: 23, Issue:2

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Calcium; Cells, Cultured; Male; Mitogen-Activated Protein Kinase 1; Muscle, Smooth, Vascular; Piperidines; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Quinolones; Rats; Rats, Sprague-Dawley

1994
Distinct mechanisms of action of V1 antagonists OPC-21268 and [d(CH2)5Tyr(Me)AVP] in mesangial cells.
    Biochemical and biophysical research communications, 1993, Jun-15, Volume: 193, Issue:2

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Calcium; Cells, Cultured; Deamino Arginine Vasopressin; Dose-Response Relationship, Drug; Glomerular Mesangium; Kinetics; Piperidines; Quinolones; Rats; Receptors, Vasopressin

1993
Effects of a novel orally effective V1-receptor antagonist, OPC-21268, on AVP-induced sympathoinhibition.
    The American journal of physiology, 1993, Volume: 264, Issue:6 Pt 2

    Topics: Administration, Oral; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Blood Pressure; Heart Rate; Injections, Intravenous; Kidney; Male; Neural Inhibition; Phenylephrine; Piperidines; Quinolones; Rabbits; Sympathetic Nervous System; Vasopressins

1993
Effects of an orally active vasopressin V1 receptor antagonist.
    Clinical and experimental pharmacology & physiology, 1993, Volume: 20, Issue:5

    Topics: Administration, Oral; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Binding Sites; Dose-Response Relationship, Drug; Female; In Vitro Techniques; Kidney; Liver; Piperidines; Quinolones; Rats; Rats, Sprague-Dawley; Receptors, Vasopressin

1993
Biochemical and pharmacological properties of SR 49059, a new, potent, nonpeptide antagonist of rat and human vasopressin V1a receptors.
    The Journal of clinical investigation, 1993, Volume: 92, Issue:1

    Topics: Animals; Arginine Vasopressin; Cattle; Cell Membrane; Humans; In Vitro Techniques; Indoles; Muscle Contraction; Piperidines; Platelet Aggregation; Pyrrolidines; Quinolones; Rats; Receptors, Vasopressin

1993
Opiate receptors within the blood-brain barrier mediate kappa agonist-induced water diuresis.
    The Journal of pharmacology and experimental therapeutics, 1993, Volume: 266, Issue:1

    Topics: Animals; Arginine Vasopressin; Blood-Brain Barrier; Cyclic AMP; Diuresis; Diuretics; Dogs; Female; Kidney Tubules, Collecting; Male; Piperidines; Pyridines; Pyrrolidines; Rabbits; Rats; Receptors, Opioid, kappa; Stimulation, Chemical; Vasopressins; Water

1993
A lack of anti-hypertensive effect of an orally effective V1 receptor antagonist, OPC-21268, in end-stage renal disease.
    Clinical nephrology, 1993, Volume: 40, Issue:1

    Topics: Adult; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Blood Pressure; Female; Humans; Hypertension, Renal; Kidney Failure, Chronic; Male; Middle Aged; Piperidines; Quinolones

1993
The effect of OPC-21268, an oral, nonpeptide arginine vasopressin V1 receptor antagonist, on a patient with congestive heart failure.
    Clinical nephrology, 1993, Volume: 40, Issue:1

    Topics: Adult; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Blood Pressure; Diabetes Mellitus, Type 2; Female; Heart Failure; Heart Rate; Humans; Kidney Failure, Chronic; Piperidines; Quinolones

1993
Protein kinase C inhibitors enhance endothelin-1 and attenuate vasopressin and angiotensin II evoked [Ca2+]i elevation in the rat cardiomyocyte.
    British journal of pharmacology, 1993, Volume: 108, Issue:1

    Topics: Alkaloids; Angiotensin II; Animals; Arginine Vasopressin; Calcium; Cells, Cultured; Cytosol; Endothelins; Fura-2; Myocardium; Piperidines; Protein Kinase C; Rats; Staurosporine

1993
Wortmannin inhibits the activation of MAP kinase following vasopressin V1 receptor stimulation.
    FEBS letters, 1995, Dec-27, Volume: 377, Issue:3

    Topics: Androstadienes; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Calcium-Calmodulin-Dependent Protein Kinases; Cells, Cultured; Deamino Arginine Vasopressin; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Fibroblasts; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Piperidines; Quinolones; Rats; Receptors, Vasopressin; Signal Transduction; Tetradecanoylphorbol Acetate; Wortmannin

1995
[Arg8]vasopressin-induced responses of the human isolated coronary artery: effects of non-peptide receptor antagonists.
    European journal of pharmacology, 1995, Oct-16, Volume: 285, Issue:2

    Topics: Adolescent; Adult; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Child; Coronary Vessels; Endothelium, Vascular; Female; Humans; In Vitro Techniques; Indoles; Male; Middle Aged; Muscle, Smooth, Vascular; Piperidines; Potassium; Pyrrolidines; Quinolones; Vasoconstrictor Agents

1995
Effects of vasopressin V1 and V2 receptor antagonists on the development of salt-induced hypertension in Dahl rats.
    Journal of cardiovascular pharmacology, 1995, Volume: 26, Issue:4

    Topics: Analysis of Variance; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Blood Pressure; Blood Pressure Determination; Diuresis; Hypertension; Male; Piperidines; Quinolones; Rats; Sodium Chloride

1995
Selective inhibition by a class III antiarrhythmic agent, E-4031, of the negative chronotropic response to parasympathetic stimulation in anesthetized dogs.
    The Journal of pharmacology and experimental therapeutics, 1996, Volume: 276, Issue:2

    Topics: Animals; Anti-Arrhythmia Agents; Arginine Vasopressin; Depression, Chemical; Dogs; Female; Heart Conduction System; Male; Myocardial Contraction; Piperidines; Pyridines; Vagus Nerve

1996
Cerebral adenosine triphosphate-sensitive K+ channels may be impaired during acute cerebral ischemia in spontaneously hypertensive rats.
    Journal of the autonomic nervous system, 1996, May-06, Volume: 58, Issue:3

    Topics: Adenosine Triphosphate; Adrenergic alpha-Antagonists; Animals; Antidiuretic Hormone Receptor Antagonists; Antihypertensive Agents; Arginine Vasopressin; Arterial Occlusive Diseases; Blood Pressure; Brain Ischemia; Carotid Arteries; Cerebral Cortex; Glyburide; Guanidines; Hypertension; Hypoglycemic Agents; Injections, Intravenous; Injections, Intraventricular; Ligation; Male; Pinacidil; Piperidines; Potassium Channels; Quinolones; Rats; Rats, Inbred SHR; Rats, Inbred WKY

1996
Functional characterization of vasopressin V1 and V2 receptors in the rabbit renal cortical collecting duct.
    Kidney international. Supplement, 1996, Volume: 55

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Calcium; Cyclic AMP; Electrophysiology; In Vitro Techniques; Kidney Cortex; Kidney Tubules, Collecting; Male; Membrane Potentials; Patch-Clamp Techniques; Piperidines; Quinolones; Rabbits; Receptors, Vasopressin; Renal Agents; Sodium

1996
kappa-Opioid agonist inhibition of osmotically induced AVP release: preferential action at hypothalamic sites.
    The American journal of physiology, 1996, Volume: 270, Issue:2 Pt 1

    Topics: Animals; Arginine Vasopressin; Culture Techniques; Hypothalamus; Male; Naltrexone; Narcotic Antagonists; Osmotic Pressure; Piperidines; Pituitary Gland, Posterior; Rats; Rats, Inbred Strains; Receptors, Opioid, kappa

1996
Pharmacological characterization of a vasopressin V1 receptor in the isolated human gastric artery.
    Life sciences, 1997, Volume: 60, Issue:4-5

    Topics: Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Arteries; Benzazepines; Humans; In Vitro Techniques; Indoles; Middle Aged; Muscle, Smooth, Vascular; Oxytocin; Piperidines; Pyrrolidines; Quinolones; Receptors, Vasopressin; Stomach; Vasoconstrictor Agents

1997
Receptor subtype for vasopressin-induced release of nitric oxide from rat kidney.
    Hypertension (Dallas, Tex. : 1979), 1997, Volume: 29, Issue:1 Pt 1

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Desoxycorticosterone; Dinoprost; Dose-Response Relationship, Drug; Enzyme Inhibitors; In Vitro Techniques; Kidney; Male; Nitric Oxide; omega-N-Methylarginine; Perfusion; Piperidines; Quinolones; Rats; Rats, Wistar; Receptors, Vasopressin; Renal Agents

1997
Role of cerebral ATP-sensitive K+ channels in arterial pressure regulation during acute cerebral ischaemia in SHR and WKY rats.
    Clinical and experimental pharmacology & physiology. Supplement, 1995, Volume: 22, Issue:1

    Topics: Adenosine Triphosphate; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Blood Pressure; Brain Chemistry; Brain Ischemia; Glyburide; Hypoglycemic Agents; Injections, Intraventricular; Male; Piperidines; Pituitary Gland; Potassium Channels; Quinolones; Rats; Rats, Inbred SHR; Rats, Inbred WKY

1995
Central histaminergic mechanisms mediate the vasopressin-induced pituitary adrenocortical stimulation.
    Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 1996, Volume: 47, Issue:4

    Topics: Adrenocorticotropic Hormone; Animals; Arginine Vasopressin; Corticosterone; Enzyme Inhibitors; Hippocampus; Histamine; Histamine Antagonists; Histidine Decarboxylase; Hypothalamo-Hypophyseal System; Hypothalamus; Male; Methylhistidines; Piperidines; Pituitary-Adrenal System; Rats; Rats, Wistar; Receptors, Histamine

1996
Modulation of genetic hypertension by short-term AVP V1A or V2 receptor antagonism in young SHR.
    The American journal of physiology, 1997, Volume: 272, Issue:2 Pt 2

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Blood Pressure; Hypertension; Male; Myocardium; Organ Size; Piperidines; Quinolones; Ramipril; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Systole; Time Factors

1997
Effect of YM087, a potent nonpeptide vasopressin antagonist, on vasopressin-induced protein synthesis in neonatal rat cardiomyocyte.
    Cardiovascular research, 1998, Volume: 38, Issue:1

    Topics: Analysis of Variance; Animals; Animals, Newborn; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Calcium; Calcium-Calmodulin-Dependent Protein Kinases; Cells, Cultured; Leucine; Myocardium; Piperidines; Protein Biosynthesis; Quinolones; Rats; Rats, Wistar; Receptors, Vasopressin; Stimulation, Chemical; Thymidine

1998
Arginine vasopressin V1-receptor antagonism in an ovine model of acute myocardial infarction.
    Journal of cardiovascular pharmacology, 1998, Volume: 32, Issue:5

    Topics: Adrenocorticotropic Hormone; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Corticotropin-Releasing Hormone; Female; Halothane; Hemodynamics; Myocardial Infarction; Piperidines; Quinolones; Renin; Sheep

1998
Characterization of receptors mediating contraction of the rat isolated small mesenteric artery and aorta to arginine vasopressin and oxytocin.
    British journal of pharmacology, 1998, Volume: 125, Issue:4

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Aorta; Arginine Vasopressin; Dose-Response Relationship, Drug; Hormone Antagonists; In Vitro Techniques; Indoles; Male; Mesenteric Arteries; Muscle Contraction; Muscle, Smooth, Vascular; Piperidines; Pyrrolidines; Quinolones; Rats; Rats, Wistar; Receptors, Oxytocin; Receptors, Vasopressin; Vasotocin

1998
In vivo and in vitro effects of AVP and V1a receptor antagonist on Cushing's syndrome due to ACTH-independent bilateral macronodular adrenocortical hyperplasia.
    Clinical endocrinology, 1998, Volume: 49, Issue:3

    Topics: Adrenal Cortex; Adrenocorticotropic Hormone; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Cells, Cultured; Cushing Syndrome; Diuretics; Drug Administration Schedule; Furosemide; Gastric Inhibitory Polypeptide; Humans; Hydrocortisone; Hyperplasia; Injections, Intravenous; Insulin; Male; Middle Aged; Piperidines; Posture; Quinolones

1998
Enhancement by arginine vasopressin of the L-type Ca2+ current in guinea pig ventricular myocytes.
    Pharmacology, 1999, Volume: 59, Issue:1

    Topics: Animals; Arginine Vasopressin; Calcium; Calcium Channels; Calcium Channels, L-Type; Dose-Response Relationship, Drug; Guinea Pigs; Heart; Isoproterenol; Piperidines; Potassium Channels; Quinolones

1999
Arginine vasopressin increases the rate of protein synthesis in isolated perfused adult rat heart via the V1 receptor.
    Molecular and cellular biochemistry, 1999, Volume: 195, Issue:1-2

    Topics: Amiloride; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Calcium; Cyclic AMP; In Vitro Techniques; Male; Myocardium; Peptide Biosynthesis; Perfusion; Piperidines; Pressure; Quinolones; Rats; Rats, Sprague-Dawley; Receptors, Vasopressin

1999
On the inotropic actions of arginine vasopressin in ventricular muscle of the guinea pig heart.
    Japanese journal of pharmacology, 1999, Volume: 81, Issue:3

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Guinea Pigs; Heart Ventricles; In Vitro Techniques; Membrane Potentials; Myocardial Contraction; Piperidines; Quinolones; Staurosporine; Ventricular Function

1999
Impaired potentiation by endothelin-1 and vasopressin of sympathetic contraction in tail artery from hypertensive rats.
    Cardiovascular research, 2000, Jan-14, Volume: 45, Issue:2

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Calcium Channel Blockers; Electric Stimulation; Endothelin Receptor Antagonists; Endothelin-1; Hypertension; In Vitro Techniques; Male; Norepinephrine; Oligopeptides; Peptides, Cyclic; Piperidines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Vasoconstriction; Vasopressins; Verapamil

2000
A molecular model of agonist and nonpeptide antagonist binding to the human V(1) vascular vasopressin receptor.
    The Journal of pharmacology and experimental therapeutics, 2000, Volume: 294, Issue:1

    Topics: Amino Acid Sequence; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Humans; Models, Molecular; Molecular Sequence Data; Mutagenesis, Site-Directed; Piperidines; Quinolones; Radioligand Assay; Rats; Receptors, Vasopressin

2000
Vasopressin receptor subtypes on mesenteric and cremasteric arterioles in rat.
    European journal of pharmacology, 2000, Jul-14, Volume: 400, Issue:1

    Topics: Animals; Arginine Vasopressin; Arterioles; Benzazepines; Male; Mesenteric Arteries; Muscle, Skeletal; Piperidines; Quinolones; Rats; Rats, Wistar; Receptors, Vasopressin; Vasoconstriction

2000
Effects of cholinergic agents on the vasopressin-mediated water transport in the isolated toad bladder.
    Comparative biochemistry and physiology. Toxicology & pharmacology : CBP, 2001, Volume: 129, Issue:2

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Arginine Vasopressin; Atropine; Biological Transport; Bufo marinus; Calcium; Calcium Channel Blockers; Carbachol; Cholinergic Agonists; Cholinergic Antagonists; In Vitro Techniques; Isotonic Solutions; Lanthanum; Osmolar Concentration; Piperidines; Pirenzepine; Urinary Bladder; Vasoconstrictor Agents; Water

2001
Effects of YM471, a nonpeptide AVP V(1A) and V(2) receptor antagonist, on human AVP receptor subtypes expressed in CHO cells and oxytocin receptors in human uterine smooth muscle cells.
    British journal of pharmacology, 2001, Volume: 133, Issue:5

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Azepines; Binding, Competitive; Calcium; Cell Membrane; CHO Cells; Cricetinae; Cyclic AMP; Dose-Response Relationship, Drug; Female; Humans; Indoles; Morpholines; Muscle, Smooth; Oxytocin; Piperidines; Pyrrolidines; Radioligand Assay; Receptors, Oxytocin; Receptors, Vasopressin; Spiro Compounds; Tritium; Uterus

2001
Intranephron localization and regulation of the V1a vasopressin receptor during chronic metabolic acidosis and dehydration in rats.
    Pflugers Archiv : European journal of physiology, 2001, Volume: 442, Issue:5

    Topics: Acidosis; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Bicarbonates; Dehydration; Down-Regulation; Homeostasis; Immunohistochemistry; Male; Nephrons; Piperidines; Polymerase Chain Reaction; Quinolones; Rats; Rats, Sprague-Dawley; Receptors, Vasopressin; RNA, Messenger; Up-Regulation; Vacuolar Proton-Translocating ATPases

2001
Effect of YM471, an orally active non-peptide arginine vasopressin receptor antagonist, on human vascular smooth muscle cells.
    Journal of hypertension, 2002, Volume: 20, Issue:9

    Topics: Antidiuretic Hormone Receptor Antagonists; Aorta; Arginine Vasopressin; Azepines; Cells, Cultured; Enzyme Activation; Humans; Hyperplasia; Hypertrophy; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Piperidines; Receptors, Vasopressin

2002
Altered cardiovascular regulation in arginine vasopressin-overexpressing transgenic rat.
    American journal of physiology. Endocrinology and metabolism, 2003, Volume: 285, Issue:6

    Topics: Adaptation, Physiological; Animals; Animals, Genetically Modified; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Blood Pressure; Carotid Artery Diseases; Hemorrhage; Hemostasis; Male; Piperidines; Quinolones; Rats; Rats, Sprague-Dawley; Receptors, Vasopressin

2003
Vasopressin antagonism by azacyclonol in hydrated rats.
    Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1963, Volume: 113

    Topics: Animals; Arginine Vasopressin; Creatine; Creatinine; Piperidines; Rats; Vasopressins

1963
[ACTION OF PC 63-I (PIPERIDINE 3,4-DIHYDROXYCINNAMATE) ON THE EFFECTS OF ACETYL-BETA-METHYLCHOLINE, VASOPRESSIN AND ALDOSTERONE].
    Comptes rendus des seances de la Societe de biologie et de ses filiales, 1964, Volume: 158

    Topics: Aldosterone; Arginine Vasopressin; Cinnamates; Diuresis; Methacholine Chloride; Methacholine Compounds; Neurosecretion; Pharmacology; Piperidines; Rats; Research; Vasopressins

1964
Facilitative effect of a novel AVP fragment analog, NC-1900, on memory retention and recall in mice.
    Peptides, 2004, Volume: 25, Issue:7

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Enzyme Activators; Male; Memory; Mental Recall; Mice; Mice, Inbred Strains; Oligopeptides; Phorbol Esters; Piperidines; Protein Kinase C; Pyrrolidonecarboxylic Acid; Receptors, Vasopressin; Stimulation, Chemical; Tetradecanoylphorbol Acetate

2004
Phospholipid mediators and MgATPase modulation causes changes in the cardiovascular effects of vasopressin in lithium carbonate-induced polyuric rats.
    Methods and findings in experimental and clinical pharmacology, 2004, Volume: 26, Issue:4

    Topics: Animals; Arginine Vasopressin; Blood Pressure; Ca(2+) Mg(2+)-ATPase; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Heart Rate; Injections, Intraperitoneal; Injections, Intravenous; Lithium Carbonate; Lypressin; Mice; Motor Activity; Neomycin; Phospholipids; Piperidines; Polyuria; Quinazolines; Quinazolinones; Rats; Rats, Wistar; Sphingosine

2004
The effect of AVP-V receptor stimulation on local GFR in the rat kidney.
    Acta physiologica Scandinavica, 2004, Volume: 182, Issue:2

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Diuresis; Female; Glomerular Filtration Rate; Kidney; Kidney Cortex; Ornipressin; Piperidines; Quinolones; Rats; Rats, Sprague-Dawley; Receptors, Vasopressin

2004
Search for an endogenous cannabinoid-mediated effect in the sympathetic nervous system.
    Naunyn-Schmiedeberg's archives of pharmacology, 2005, Volume: 371, Issue:1

    Topics: Animals; Arginine Vasopressin; Benzoxazines; Blood Pressure; Calcium Channel Blockers; Cannabinoid Receptor Modulators; Decerebrate State; Electric Stimulation; Heart Rate; Male; Morpholines; Naphthalenes; Norepinephrine; Phenylephrine; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptors, Adrenergic, alpha-2; Receptors, Presynaptic; Receptors, Vasopressin; Rimonabant; Sympathetic Nervous System; Sympathomimetics; Synaptic Transmission

2005
Effects of YM218, a nonpeptide vasopressin V1A receptor-selective antagonist, on human vasopressin and oxytocin receptors.
    Pharmacological research, 2005, Volume: 51, Issue:3

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; CHO Cells; Cricetinae; Dose-Response Relationship, Drug; Female; Humans; Piperidines; Protein Binding; Receptors, Oxytocin; Receptors, Vasopressin; Second Messenger Systems; Vasopressins

2005
Vasopressin promotes cardiomyocyte hypertrophy via the vasopressin V1A receptor in neonatal mice.
    European journal of pharmacology, 2007, Mar-22, Volume: 559, Issue:2-3

    Topics: Animals; Animals, Newborn; Arginine Vasopressin; Atrial Natriuretic Factor; Cardiomegaly; Cell Enlargement; Cells, Cultured; Disease Models, Animal; DNA; Dose-Response Relationship, Drug; Extracellular Signal-Regulated MAP Kinases; Immunohistochemistry; Male; Mice; Mice, Knockout; Myocytes, Cardiac; Phosphorylation; Piperidines; Protein Biosynthesis; Quinolones; Receptors, Vasopressin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors; Transcription, Genetic; Vasoconstrictor Agents

2007
Cardiovascular effects of carbachol microinjected into the bed nucleus of the stria terminalis of the rat brain.
    Brain research, 2007, Apr-27, Volume: 1143

    Topics: Animals; Arginine Vasopressin; Atropine; Blood Pressure; Carbachol; Cholinergic Agonists; Dose-Response Relationship, Drug; Drug Interactions; Heart Rate; Male; Microinjections; Muscarinic Antagonists; Nicotinic Antagonists; Pentolinium Tartrate; Piperidines; Rats; Rats, Wistar; Septal Nuclei

2007
Effect of YM218, a nonpeptide vasopressin V(1A) receptor-selective antagonist, on rat mesangial cell hyperplasia and hypertrophy.
    Vascular pharmacology, 2007, Volume: 46, Issue:6

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Cell Proliferation; Cell Size; Cells, Cultured; DNA Replication; Dose-Response Relationship, Drug; Endothelin-1; Hyperplasia; Male; Mesangial Cells; Piperidines; Protein Biosynthesis; Pyrimidines; Rats; Rats, Wistar; Receptor, Endothelin A; Receptors, Vasopressin; Sulfonamides

2007
Vasopressin-induced nitric oxide production in rat inner medullary collecting duct is dependent on V2 receptor activation of the phosphoinositide pathway.
    American journal of physiology. Renal physiology, 2007, Volume: 293, Issue:2

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Calcium; Calcium-Transporting ATPases; Cyclic AMP-Dependent Protein Kinases; Kidney Medulla; Kidney Tubules, Collecting; Male; Nitric Oxide; Phosphatidylinositols; Piperidines; Quinolones; Rats; Rats, Sprague-Dawley; Receptors, Vasopressin; Signal Transduction; Spectrometry, Fluorescence; Type C Phospholipases; Vasopressins

2007
Bidirectional roles of the brain 2-arachidonoyl-sn-glycerol in the centrally administered vasopressin-induced adrenomedullary outflow in rats.
    European journal of pharmacology, 2008, Mar-17, Volume: 582, Issue:1-3

    Topics: Adrenal Medulla; Animals; Arachidonic Acids; Arginine Vasopressin; Benzoxazines; Brain; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Cannabinoid Receptor Modulators; Catecholamines; Cyclohexanones; Dose-Response Relationship, Drug; Endocannabinoids; Enzyme Inhibitors; Epinephrine; Glycerides; Indoles; Injections, Intraventricular; Male; Morpholines; Naphthalenes; Norepinephrine; Organophosphonates; Piperidines; Pyrazoles; Rats; Rats, Wistar

2008
Vasopressin increases type IV collagen production through the induction of transforming growth factor-beta secretion in rat mesangial cells.
    Pharmacological research, 2008, Volume: 57, Issue:2

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Cells, Cultured; Collagen Type IV; Dose-Response Relationship, Drug; Male; Mesangial Cells; Morpholines; Piperidines; Rats; Rats, Wistar; Spiro Compounds; Transforming Growth Factor beta

2008
Involvement of NO and MEK/ERK pathway in enhancement of endothelin-1-induced mesenteric artery contraction in later-stage type 2 diabetic Goto-Kakizaki rat.
    American journal of physiology. Heart and circulatory physiology, 2009, Volume: 296, Issue:5

    Topics: Angiotensin II; Animals; Arginine Vasopressin; Butadienes; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Endothelin-1; Endothelins; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Male; MAP Kinase Kinase Kinases; Mesenteric Arteries; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitriles; Nitroarginine; Nitroprusside; Oligopeptides; Peptide Fragments; Peptides, Cyclic; Piperidines; Rats; Rats, Wistar; Receptor, Endothelin A; Receptor, Endothelin B; Signal Transduction; Vasoconstriction; Vasodilation

2009
CB(1) modulation of hormone secretion, neuronal activation and mRNA expression following extracellular volume expansion.
    Experimental neurology, 2010, Volume: 224, Issue:1

    Topics: Analysis of Variance; Animals; Arginine Vasopressin; Catheters, Indwelling; Extracellular Fluid; Hypothalamus; Immunoassay; Immunohistochemistry; Male; Neurons; Nitrates; Oxytocin; Piperidines; Proto-Oncogene Proteins c-fos; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Reverse Transcriptase Polymerase Chain Reaction; Rimonabant; RNA, Messenger

2010
Vasopressin induces human mesangial cell growth via induction of vascular endothelial growth factor secretion.
    Neuropeptides, 2011, Volume: 45, Issue:2

    Topics: Arginine Vasopressin; Benzazepines; Cell Proliferation; Cells, Cultured; Collagen Type IV; Dose-Response Relationship, Drug; Humans; Mesangial Cells; Piperidines; Receptors, Vasopressin; Vascular Endothelial Growth Factor A

2011
In vitro and in vivo pharmacological characterisation of the potent and selective vasopressin V(1A) receptor antagonist 4-[4-(4-Chloro-phenyl)-5-[1,2,3]triazol-2-ylmethyl-4H-[1,2,4]triazol-3-yl]-piperidin-1-yl-(3,5-difluoro-phenyl) methanone (PF-00738245)
    European journal of pharmacology, 2011, Nov-30, Volume: 670, Issue:2-3

    Topics: Administration, Oral; Animals; Antidiuretic Hormone Receptor Antagonists; Aorta; Arginine Vasopressin; Blood Circulation; Capsaicin; CHO Cells; Cricetinae; Cricetulus; Dogs; Female; Humans; Male; Models, Biological; Myometrium; Piperidines; Rats; Receptors, Oxytocin; Receptors, Vasopressin; Substrate Specificity; Triazoles

2011
Tonic regulation of GABAergic synaptic activity on vasopressin neurones by cannabinoids.
    Journal of neuroendocrinology, 2012, Volume: 24, Issue:4

    Topics: Action Potentials; Animals; Arginine Vasopressin; Calcium; Cannabinoid Receptor Modulators; Dose-Response Relationship, Drug; Egtazic Acid; Female; GABAergic Neurons; In Vitro Techniques; Inhibitory Postsynaptic Potentials; Neurons; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Rimonabant; Vasopressins

2012
Estradiol and testosterone regulate arginine-vasopressin expression in SH-SY5Y human female neuroblastoma cells through estrogen receptors-α and -β.
    Endocrinology, 2013, Volume: 154, Issue:6

    Topics: Arginine Vasopressin; Cell Line, Tumor; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Fulvestrant; Gene Expression Regulation, Neoplastic; Humans; Neuroblastoma; Nitriles; Phenols; Piperidines; Pyrazoles; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; Testosterone

2013
Melanocortin Receptor Agonists Facilitate Oxytocin-Dependent Partner Preference Formation in the Prairie Vole.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2015, Volume: 40, Issue:8

    Topics: alpha-MSH; Animals; Arginine Vasopressin; Arvicolinae; Brain; Dose-Response Relationship, Drug; Early Growth Response Protein 1; Female; Male; Oxytocin; Pair Bond; Peptides, Cyclic; Piperidines; Pyrrolidines; Receptors, Melanocortin; Receptors, Oxytocin; Sex Characteristics; Sexual Behavior, Animal; Vasotocin

2015
Opposite effects of central oxytocin and arginine vasopressin on changes in gastric motor function induced by chronic stress.
    Peptides, 2017, Volume: 87

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzoxazines; Brain; Corticotropin-Releasing Hormone; Gastric Emptying; Gastrointestinal Motility; Hypothalamus; Indoles; Microdialysis; Oxytocin; Piperidines; Pituitary-Adrenal System; Pyrrolidines; Rats; Receptors, Oxytocin; Stress, Physiological

2017